| 标题 |
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of the American Academy of Dermatology 作者:Zhang J; Boesjes CM; Loman L; Kamphuis E; Romeijn MLE; et al 出版日期:2024/08/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)